MedTrace Logo

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

NCT06482957 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2100

Last updated 2025-09-19

No results posted yet for this study

Summary

This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.

Conditions

  • Sarcoma

Interventions

OTHER

Surveys

Complete surveys

OTHER

Blood Collection

Undergo blood collection

OTHER

Saliva Collection

Undergo salvia collection

OTHER

Urine Collection

Undergo urine collection

OTHER

Stool Collection

Undergo stool collection

OTHER

Tissue collection

Undergo tissue collection

OTHER

Physical Activity Monitoring

FitBit will be worn to track physical activity

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • Debra Friedman, MD · Vanderbilt University/Ingram Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2028-04-30
Completion
2029-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06482957 on ClinicalTrials.gov